Revised SPC: Eylea (aflibercept) 40mg/ml solution for injection in a vial

SPC advises that for wet age-related macular degeneration, treatment intervals greater than four months or shorter than 4 weeks between injections have not been studied.

Source:

electronic Medicines compendium